Many IDHWT tumours had alterations impacting WNT [59–63] signalling pathway genes (58%) including CREBBP(4), KLF4(2) [64, 65], TERT(2) [17], and APC(3) [66–70]; however, targeting this pathway is currently challenging. This evidence concerns the gene KLF4 and neoplasm.